S. 2973 · 118th Congress

Modernizing and Ensuring PBM Accountability Act

Introduced on Sep 28, 2023 by Ron Wyden (D-OR). Latest action (Dec 7, 2023): Placed on Senate Legislative Calendar under General Orders. Calendar No. 266.

Stage
Reported by committee
Introduced
Sep 28, 2023
Cosponsors
0
Policy area
Health
Open in the Congress explorerCongress.govAlert me

Progress

The furthest stage the measure reached. Simple and concurrent resolutions do not go to the President.

  1. Introduced
  2. Reported by committee
  3. 3Passed one chamber
  4. 4Passed both chambers
  5. 5Sent to the President
  6. 6Became law

Official title

A bill to amend titles XVIII and XIX of the Social Security Act to establish requirements relating to pharmacy benefit managers under the Medicare and Medicaid programs, and for other purposes.

Subjects

  • Accounting and auditing
  • Aging
  • Congressional oversight
  • Contracts and agency
  • Drug safety, medical device, and laboratory regulation
  • Government information and archives
  • Government studies and investigations
  • Health care costs and insurance
  • Health care coverage and access
  • Health care quality
  • Health programs administration and funding
  • Medicaid
  • Medicare
  • Performance measurement
  • Prescription drugs
  • Public participation and lobbying
  • Retail and wholesale trades
  • User charges and fees

Summary

The Congressional Research Service has not summarized this measure yet.

Sponsor and cosponsors

Cosponsors by party as of the day they signed on. Original cosponsors signed on the day of introduction.

Ron WydenD-ORSponsor

No cosponsors.

Roll calls

Recorded votes on the measure. Most measures move by voice vote or unanimous consent, which record no individual positions.

No recorded roll call on this measure: it moved by voice vote or unanimous consent, or has not reached the floor.

History

Every action as published, oldest first. Roll calls link to how each member voted.

  1. Sep 28, 2023Introduced in Senate
  2. Sep 28, 2023 · SenateRead twice and referred to the Committee on Finance.
  3. Dec 7, 2023Committee on Finance. Reported by Senator Wyden with an amendment in the nature of a substitute. With written report No. 118-122.
  4. Dec 7, 2023 · SenateCommittee on Finance. Reported by Senator Wyden with an amendment in the nature of a substitute. With written report No. 118-122.
  5. Dec 7, 2023 · SenatePlaced on Senate Legislative Calendar under General Orders. Calendar No. 266.

Committees

Committees and subcommittees the measure was referred to.

Agencies in its committees' jurisdiction

Analisa's mapping of committee jurisdiction to federal agencies; the bill may touch others, or none of these.

Who lobbied on it

Organizations whose lobbying reports (LD-2) name this measure. Spending is what they reported for those quarters on all issues, not on this measure alone.

  1. PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA20 reports
    $37.4M reported (all issues)
  2. UNITEDHEALTH GROUP INCORPORATED15 reports
  3. BIOTECHNOLOGY INNOVATION ORGANIZATION10 reports
    $8.9M reported (all issues)
  4. EISAI INC.10 reports
    $3.1M reported (all issues)Federal contractor: EISAI INC.AI match · 100%
  5. INDEPENDENT PHARMACY COOPERATIVE10 reports
    $270K reported (all issues)Federal contractor: INDEPENDENT PHARMACY COOPERATIVEAI match · 99%
  6. Pharmaceutical Care Management Association (PCMA)9 reports
    $590K reported (all issues)
  7. TAKEDA PHARMACEUTICALS AMERICA, INC.9 reports
    $3M reported (all issues)Federal contractor: TAKEDA PHARMACEUTICALS AMERICA, INC.$1.6M in contracts, FY2026AI match · 100%
  8. BRISTOL-MYERS SQUIBB COMPANY8 reports
    $2M reported (all issues)Federal contractor: BRISTOL-MYERS SQUIBB COMPANY$8.8M in contracts, FY2026AI match · 100%
  9. MERCK & CO., INC.8 reports
    Federal contractor: MERCK SHARP & DOHME LLC$445.3K in contracts, FY2026AI match · 100%
  10. PRIME THERAPEUTICS LLC8 reports
    $370K reported (all issues)
  11. Cencora fka AmerisourceBergen Corporation6 reports
    $300K reported (all issues)
  12. Cystic Fibrosis Foundation6 reports
    $1.2M reported (all issues)
  13. ELEVANCE HEALTH, INC.6 reports
    $7.6M reported (all issues)
  14. EMD SERONO, INC.6 reports
    $1.9M reported (all issues)
  15. GSK (fka GLAXOSMITHKLINE INC.)6 reports
    $7.1M reported (all issues)
  16. NATIONAL ASSOCIATION OF CHAIN DRUG STORES, INC.6 reports
    $4.2M reported (all issues)
  17. 340B HEALTH5 reports
    $1.6M reported (all issues)
  18. AMERICAN PHARMACIES, INC.5 reports
    $300K reported (all issues)
  19. American Pharmacy Cooperative, Inc.5 reports
    $150K reported (all issues)
  20. BLUE CROSS BLUE SHIELD ASSOCIATION5 reports
    $400K reported (all issues)
  21. CVS HEALTH5 reports
    $11M reported (all issues)
  22. Cambia Health Solutions (formerly known as The Regence Group)5 reports
    $400K reported (all issues)
  23. FOOD MARKETPLACE INC.5 reports
    $1.7M reported (all issues)
  24. INTRA-CELLULAR THERAPIES, INC.5 reports
    $250K reported (all issues)
  25. KAISER FOUNDATION HEALTH PLAN INC.5 reports
    $2.9M reported (all issues)Federal contractor: KAISER FOUNDATION HEALTH PLAN OF WASHINGTONAI match · 97%
  26. Lundbeck Pharmaceuticals LLC5 reports
    $200K reported (all issues)
  27. NATIONAL COMMUNITY PHARMACISTS ASSOCIATION5 reports
    $1.8M reported (all issues)Federal contractor: NATIONAL COMMUNITY PHARMACISTS ASSOCIATIONAI match · 100%
  28. NATIONAL MULTIPLE SCLEROSIS SOCIETY5 reports
    $319.3K reported (all issues)
  29. NOVARTIS CORPORATION5 reports
    $6.9M reported (all issues)Federal contractor: NOVARTIS PHARMACEUTICALS CORPORATION$36.2M in contracts, FY2026AI match · 100%
  30. National Community Pharmacists Association (NCPA)5 reports
    $250K reported (all issues)Federal contractor: NATIONAL COMMUNITY PHARMACISTS ASSOCIATIONAI match · 100%
  31. SANOFI US SERVICES INC5 reports
  32. St Luke's Health Plan, Inc.5 reports
    $50K reported (all issues)
  33. The Cigna Group and subsidiaries (Formerly Cigna Corporation5 reports
    $10.2M reported (all issues)
  34. VERTEX PHARMACEUTICALS INCORPORATED5 reports
  35. WAKEFERN FOOD CORP.5 reports
  36. AMGEN INC.4 reports
    Federal contractor: AMGEN INC.AI match · 99%
  37. CENCORA, INC.4 reports
  38. Government Counsel, LLC (obo) Prime Therapeutics4 reports
    $40K reported (all issues)
  39. PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION4 reports
    $17.8M reported (all issues)
  40. The Leukemia & Lymphoma Society4 reports
    $1M reported (all issues)

Reports filed in 2023, 2024, 2025, 2026.

Sources and method

Every figure on this page traces to these records.

  • Bill status: bills and resolutions, sponsors, actions, subjects and CRS summaries (U.S. Government Publishing Office (GovInfo), from Congress.gov (Library of Congress))GovInfo Bill Status bulk data (Congress.gov; summaries by the Congressional Research Service) · data current to Oct 6, 2026 · loaded Oct 6, 2026 · license: Public domain (U.S. Government work, 17 U.S.C. § 105)
  • Members of Congress, their terms, committees and identifiers (The @unitedstates project (from the Biographical Directory of the U.S. Congress, the House and the Senate))unitedstates/congress-legislators: legislators, committees and current committee membership · data current to Oct 3, 2026 · loaded Oct 3, 2026 · license: CC0 1.0 (public domain dedication)
  • House roll-call votes (Office of the Clerk, U.S. House of Representatives)Office of the Clerk, U.S. House of Representatives, roll-call vote records · data current to Oct 3, 2026 · loaded Oct 3, 2026 · license: Public domain (U.S. Government work, 17 U.S.C. § 105)
  • Senate roll-call votes and DW-NOMINATE scores (Voteview (UCLA Department of Political Science))Lewis, Jeffrey B., Keith Poole, Howard Rosenthal, Adam Boche, Aaron Rudkin, and Luke Sonnet (2026). Voteview: Congressional Roll-Call Votes Database. https://voteview.com/ · data current to Oct 3, 2026 · loaded Oct 3, 2026 · license: Free to use with the required citation
  • Lobbying disclosures (LD-1 registrations, LD-2 quarterly reports, LD-203 contribution reports) (Clerk of the U.S. House of Representatives)Clerk of the House, Lobbying Disclosure Act filings (organizations only; lobbyists' names are not loaded) · data current to Oct 6, 2026 · loaded Oct 6, 2026 · license: Public domain (U.S. Government work, 17 U.S.C. § 105)
  • Positions are shown only where a roll call recorded them; voice votes and unanimous consent record none.
  • Money and votes are shown side by side; neither explains the other.